Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 5
2007 3
2008 3
2009 5
2010 4
2011 2
2012 6
2013 6
2014 1
2015 10
2016 7
2017 5
2018 8
2019 13
2020 20
2021 21
2022 24
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Luppi F, et al. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):291-300. Epub 2020 Oct 23. Clin Exp Rheumatol. 2020. PMID: 33095142 Free article. Review.
Immunomodulatory treatment of interstitial lung disease.
van den Bosch L, Luppi F, Ferrara G, Mura M. van den Bosch L, et al. Among authors: luppi f. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221117002. doi: 10.1177/17534666221117002. Ther Adv Respir Dis. 2022. PMID: 35938712 Free PMC article. Review.
Lung complications of Sjogren syndrome.
Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Luppi F, et al. Eur Respir Rev. 2020 Aug 18;29(157):200021. doi: 10.1183/16000617.0021-2020. Print 2020 Sep 30. Eur Respir Rev. 2020. PMID: 32817113 Free PMC article. Review.
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Salvarani C, Massari M, Costantini M, Merlo DF, Mariani GL, Viale P, Nava S, Guaraldi G, Dolci G, Boni L, Savoldi L, Bruzzi P, Turrà C, Catanoso M, Marata AM, Barbieri C, Valcavi A, Franzoni F, Cavuto S, Mazzi G, Corsini R, Trapani F, Bartoloni A, Barisione E, Barbieri C, Burastero GJ, Pan A, Inojosa W, Scala R, Burattini C, Luppi F, Codeluppi M, Tarek KE, Cenderello G, Salio M, Foti G, Dongilli R, Bajocchi G, Negri EA, Ciusa G, Fornaro G, Bassi I, Zammarchi L, Aloè T, Facciolongo N. Salvarani C, et al. Among authors: luppi f. Eur Respir J. 2022 Oct 20;60(4):2200025. doi: 10.1183/13993003.00025-2022. Print 2022 Oct. Eur Respir J. 2022. PMID: 35361632 Free PMC article. Clinical Trial.
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.
Faverio P, Luppi F, Rebora P, D'Andrea G, Stainer A, Busnelli S, Catalano M, Modafferi G, Franco G, Monzani A, Galimberti S, Scarpazza P, Oggionni E, Betti M, Oggionni T, De Giacomi F, Bini F, Bodini BD, Parati M, Bilucaglia L, Ceruti P, Modina D, Harari S, Caminati A, Intotero M, Sergio P, Monzillo G, Leati G, Borghesi A, Zompatori M, Corso R, Valsecchi MG, Bellani G, Foti G, Pesci A. Faverio P, et al. Among authors: luppi f. Respir Res. 2022 Mar 21;23(1):65. doi: 10.1186/s12931-022-01994-y. Respir Res. 2022. PMID: 35313890 Free PMC article.
137 results